220 related articles for article (PubMed ID: 12208250)
1. Cancer-associated retinopathy associated with invasive thymoma.
Katsuta H; Okada M; Nakauchi T; Takahashi Y; Yamao S; Uchida S
Am J Ophthalmol; 2002 Sep; 134(3):383-9. PubMed ID: 12208250
[TBL] [Abstract][Full Text] [Related]
2. Choroidal neovascularization associated with cancer-associated retinopathy.
Querques G; Thirkill CE; Hagege H; Soubrane G; Souied EH
Acta Ophthalmol; 2010 Aug; 88(5):571-5. PubMed ID: 19141145
[TBL] [Abstract][Full Text] [Related]
3. Invasive thymoma with paraneoplastic retinopathy.
Yamada G; Ohguro H; Aketa K; Itoh T; Shijubo N; Takahashi H; Fujiwara O; Satoh M; Ohtsuka K; Abe S
Hum Pathol; 2003 Jul; 34(7):717-9. PubMed ID: 12874770
[TBL] [Abstract][Full Text] [Related]
4. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
Guy J; Aptsiauri N
Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated retinopathy in a patient with endometrial cancer.
Ohkawa T; Kawashima H; Makino S; Shimizu Y; Shimizu H; Sekiguchi I; Tsuchida S
Am J Ophthalmol; 1996 Nov; 122(5):740-2. PubMed ID: 8909222
[TBL] [Abstract][Full Text] [Related]
6. [Carcinoma-associated retinopathy: a review with clinical examples].
Sobottka B; Schlote T; Besch D; Djelebova T; Wilhelm H; Zrenner E
Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
[TBL] [Abstract][Full Text] [Related]
7. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration.
Heckenlively JR; Fawzi AA; Oversier J; Jordan BL; Aptsiauri N
Arch Ophthalmol; 2000 Nov; 118(11):1525-33. PubMed ID: 11074809
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic cone dysfunction: an unusual visual remote effect of cancer.
Jacobson DM; Thirkill CE
Arch Ophthalmol; 1995 Dec; 113(12):1580-2. PubMed ID: 7487640
[No Abstract] [Full Text] [Related]
10. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
[TBL] [Abstract][Full Text] [Related]
11. Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy.
Savchenko MS; Bazhin AV; Shifrina ON; Demoura SA; Kogan EA; Chuchalin AG; Philippov PP
Lung Cancer; 2003 Sep; 41(3):363-7. PubMed ID: 12928127
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma.
Salgia R; Hedges TR; Rizk M; Reimer RH; Skarin AT
Lung Cancer; 1998 Nov; 22(2):149-52. PubMed ID: 10022222
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated retinopathy with presumed vasculitis.
Suzuki T; Obara Y; Sato Y; Saito G; Ichiwata T; Uchiyama T
Am J Ophthalmol; 1996 Jul; 122(1):125-7. PubMed ID: 8659589
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated retinopathy during treatment for small-cell lung carcinoma.
Kashiwabara K; Nakamura H; Kishi K; Yagyu H; Sarashina G; Kobayashi K; Matsuoka T
Intern Med; 1999 Jul; 38(7):597-601. PubMed ID: 10435368
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune retinopathy in the absence of cancer.
Mizener JB; Kimura AE; Adamus G; Thirkill CE; Goeken JA; Kardon RH
Am J Ophthalmol; 1997 May; 123(5):607-18. PubMed ID: 9152066
[TBL] [Abstract][Full Text] [Related]
17. Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy.
Adamus G; Amundson D; MacKay C; Gouras P
Arch Ophthalmol; 1998 Feb; 116(2):251-3. PubMed ID: 9488286
[No Abstract] [Full Text] [Related]
18. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
[TBL] [Abstract][Full Text] [Related]
19. [Eclizumab in the treatment of myasthenia gravis crisis complicating invasive thymoma: a case study of efficacy].
Yoshizumi K; Kimura T; Ukon S; Watanabe S; Kasama S; Takeda M
Rinsho Shinkeigaku; 2020 Dec; 60(12):865-868. PubMed ID: 33229836
[TBL] [Abstract][Full Text] [Related]
20. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
